Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer

NCT02643056 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Advanced Head and Neck Squamous Cancer

Interventions

DRUG: Panitumumab

Sponsor

Southern Europe New Drug Organization

Collaborators

[object Object]